Skip to main content

and
  1. No Access

    Article

    A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma

    Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancers in adults, and microRNAs (miRNAs) differentially expressed in ccRCC tumors have been identified and proposed to predict prog...

    Yu-Zheng Ge, Ran Wu, Hui **n, Meng Zhu in Journal of Cancer Research and Clinical On… (2015)

  2. Article

    Open Access

    Serial cfDNA assessment of response and resistance to EGFR-TKI for patients with EGFR-L858R mutant lung cancer from a prospective clinical trial

    Detecting epidermal growth factor receptor (EGFR) activating mutations in plasma could guide EGFR-tyrosine kinase inhibitor (EGFR-TKI) treatment for advanced non-small cell lung cancer (NSCLC). However, dynamic q...

    Qing Zhou, **-Ji Yang, Zhi-Hong Chen, Xu-Chao Zhang in Journal of Hematology & Oncology (2016)

  3. No Access

    Article

    Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)

    The safety and efficacy of intraoperative chemotherapy in colorectal cancer have not yet been extensively investigated. This randomized control trial was designed to compare the safety and efficacy of intraope...

    Rong-xin Zhang, Jun-zhong Lin, Jian Lei in Journal of Cancer Research and Clinical On… (2017)

  4. No Access

    Article

    Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm

    The Notch signaling pathway contributes to the pathogenesis of a wide spectrum of human cancers, including hematopoietic malignancies. Its functions are highly dependent on the specific cellular context. Gain-...

    Guangyao Kong, **aona You, Zhi Wen, Yuan-I Chang, Shuiming Qian in Leukemia (2019)

  5. Article

    Open Access

    MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors

    MET amplification plays an important role in the development of non-small-cell lung cancer (NSCLC) either de novo or in resistance to epidermal growth factor receptor tyrosine–kinase inhibitor (EGFR-TKI) settings...

    Lun-** Peng, Guang-Ling Jie, An-Na Li, Si-Yang Liu in Experimental Hematology & Oncology (2021)

  6. Article

    Open Access

    Enhanced cellular therapy: revolutionizing adoptive cellular therapy

    Enhanced cellular therapy has emerged as a novel concept following the basis of cellular therapy. This treatment modality applied drugs or biotechnology to directly enhance or genetically modify cells to enhan...

    Meng-Yao Xu, Na Zeng, Chen-Qian Liu, Jian-Xuan Sun in Experimental Hematology & Oncology (2024)